Suppr超能文献

mRNA新冠疫苗接种的行为和健康结果:日本中小企业的一项病例对照研究

Behavioral and Health Outcomes of mRNA COVID-19 Vaccination: A Case-Control Study in Japanese Small and Medium-Sized Enterprises.

作者信息

Nakatani Eiji, Morioka Hisayo, Kikuchi Takayuki, Fukushima Masanori

机构信息

Research Support Center, Shizuoka General Hospital, Shizuoka, JPN.

Health Data Science, Learning Health Society Institute, Nagoya, JPN.

出版信息

Cureus. 2024 Dec 13;16(12):e75652. doi: 10.7759/cureus.75652. eCollection 2024 Dec.

Abstract

Background Despite ongoing waves of Coronavirus disease 2019 (COVID-19) infections, including significant surges such as the 10th wave, understanding the impact of messenger RNA (mRNA) COVID-19 vaccination on infection risk and associated behavioral changes remains crucial. This study aims to urgently evaluate the effects of mRNA COVID-19 vaccination on COVID-19 infection rates and related behaviors among participants of the Yamato Project, which includes employees of Japanese small and medium-sized enterprises (SMEs). Methods A case-control study was conducted using data collected from a survey administered by the Japan Small and Medium Enterprise Management Council in December 2023. Participants included individuals who were part of the Yamato Project, not necessarily limited to SME employees. The survey gathered information on demographic characteristics, COVID-19 infection status, vaccination history, health status before January 2020, and various preventive behaviors. The primary outcome was the presence or absence of COVID-19 infection. Data were analyzed using univariate and multivariate logistic regression models to calculate odds ratios (ORs) and 95% confidence intervals (CIs) for the association between vaccination status and COVID-19 infection. Results A total of 913 participants were included in the final analysis. The adjusted ORs for COVID-19 infection among vaccinated individuals compared to unvaccinated individuals were 1.85 (95% CI: 1.33-2.57, p < 0.001). The odds of contracting COVID-19 increased with the number of vaccine doses: one to two doses (OR: 1.63, 95% CI: 1.08-2.46, p = 0.020), three to four doses (OR: 2.04, 95% CI: 1.35-3.08, p = 0.001), and five to seven doses (OR: 2.21, 95% CI: 1.07-4.56, p = 0.033). Behavioral analysis indicated that a reduced frequency of bathing and exercising was significantly associated with higher COVID-19 infection rates (p < 0.05). Conclusions The study observed a higher reported incidence of COVID-19 infection among vaccinated individuals during the pandemic period, which increased with the number of vaccine doses received. This paradoxical finding may be influenced by various factors, including immune response mechanisms, such as antibody-dependent enhancement (ADE) or original antigenic sin, behavioral changes, and exposure risk. Understanding these factors is crucial for urgently enhancing public health strategies and vaccination programs.

摘要

背景 尽管2019冠状病毒病(COVID-19)感染持续出现多波疫情,包括第10波等显著激增情况,但了解信使核糖核酸(mRNA) COVID-19疫苗接种对感染风险及相关行为变化的影响仍然至关重要。本研究旨在紧急评估mRNA COVID-19疫苗接种对大和项目参与者中COVID-19感染率及相关行为的影响,大和项目参与者包括日本中小企业(SME)的员工。方法 采用日本中小企业管理协会于2023年12月进行的一项调查收集的数据进行病例对照研究。参与者包括大和项目的成员,不一定限于中小企业员工。该调查收集了人口统计学特征、COVID-19感染状况、疫苗接种史、2020年1月前的健康状况以及各种预防行为等信息。主要结局是是否感染COVID-19。使用单因素和多因素逻辑回归模型分析数据,以计算疫苗接种状况与COVID-19感染之间关联的比值比(OR)和95%置信区间(CI)。结果 最终分析共纳入913名参与者。接种疫苗个体与未接种疫苗个体相比,COVID-19感染的校正OR为1.85(95%CI:1.33 - 2.57,p < 0.001)。感染COVID-19的几率随疫苗接种剂量数增加而升高:1至2剂(OR:1.63,95%CI:1.08 - 2.46,p = 0.020),3至4剂(OR:2.04,95%CI:1.35 - 3.08,p = 0.001),5至7剂(OR:2.21,95%CI:1.07 - 4.56,p = 0.033)。行为分析表明,洗澡和锻炼频率降低与较高的COVID-19感染率显著相关(p < 0.05)。结论 该研究观察到在疫情期间接种疫苗个体中报告的COVID-19感染发生率较高,且随接种疫苗剂量数增加而升高。这一矛盾的发现可能受多种因素影响,包括免疫反应机制,如抗体依赖增强(ADE)或原始抗原罪、行为变化和暴露风险。了解这些因素对于紧急加强公共卫生策略和疫苗接种计划至关重要。

相似文献

5
The relationship between COVID-19 vaccination status in pregnancy and birthweight.妊娠期 COVID-19 疫苗接种状况与出生体重的关系。
Am J Obstet Gynecol MFM. 2023 Sep;5(9):101057. doi: 10.1016/j.ajogmf.2023.101057. Epub 2023 Jun 15.

本文引用的文献

1
Waning Immunity after the BNT162b2 Vaccine in Israel.以色列接种 BNT162b2 疫苗后的免疫力下降。
N Engl J Med. 2021 Dec 9;385(24):e85. doi: 10.1056/NEJMoa2114228. Epub 2021 Oct 27.
8
Looking beyond COVID-19 vaccine phase 3 trials.展望 COVID-19 疫苗 III 期临床试验之外。
Nat Med. 2021 Feb;27(2):205-211. doi: 10.1038/s41591-021-01230-y. Epub 2021 Jan 19.
9
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.mRNA-1273 新型冠状病毒疫苗的有效性和安全性。
N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.
10
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验